<DOC>
	<DOC>NCT03080324</DOC>
	<brief_summary>The purpose of this study is to determine the non-inferiority of the efficacy of sublingual given fentanyl versus endovenous given fentanyl for patients in the emergency departement.</brief_summary>
	<brief_title>Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room</brief_title>
	<detailed_description>Fentanyl endovenous (ev) is an excellent analgesic drug for pain relief in acute traumatic pain. Fentanyl sublingual (Abstral Â®) is an excellent analgesic drug in the breakthrough pain relief in oncologic patients. The immediate (10 minutes) effect and the ease of administration of sublingual fentanyl could be a possibility for a fast pain relief in remote areas such as mountain rescue missions. Patients will be recruited according to a randomized list to fentanyl ev or fentanyl sublingual versus placebo oral or placebo ev. Safety issues like control of vital signs will be warranted</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Trauma on the limbs with a pain score of 4 or more ASA I II children &lt; 18 years cognitive impairment: brain injury, intoxication, analgesia weight under 50 kg and more then 100 kg other injuries like chest trauma with respiratory insufficiency, suspect liver or spleen injury, amputation; chronic analgesic use or misuse allergy fear of needles pregnancy speech difficulties</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Fentanyl</keyword>
	<keyword>Transmucosal administration</keyword>
	<keyword>Endovenous administration</keyword>
	<keyword>Pain therapy</keyword>
</DOC>